Comparison of a novel, rapid chromogenic biochemical assay, the carba NP test, with the modified hodge test for detection of carbapenemase-producing gram-negative bacilli

Journal of Clinical Microbiology

Volumn 51, Issue 9, 2013, Pages 3097-3101

  Vasoo, Shawn ^a   Cunningham, Scott A ^a   Kohner, Peggy C ^a   Simner, Patricia J ^a   Mandrekar, Jayawant N ^a   Lolans, Karen ^b   Hayden, Mary K ^b   Patel, Robin ^a  

^a MAYO CLINIC   (United States)

^b RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAPENEMASE;

ARTICLE; ASSAY; BACTERIUM DETECTION; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATION; BIOCHEMISTRY; CHROMOGENIC RAPID TEST; CONTROLLED STUDY; DIAGNOSTIC TEST; DIAGNOSTIC TEST ACCURACY STUDY; GRAM NEGATIVE BACTERIUM; INTERMETHOD COMPARISON; KLEBSIELLA PNEUMONIAE; MODIFIED HODGE TEST; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROVIDENCIA STUARTII; PSEUDOMONAS AERUGINOSA; SENSITIVITY AND SPECIFICITY;

BACTERIAL PROTEINS; BETA-LACTAMASES; CHROMOGENIC COMPOUNDS; COLORIMETRY; GRAM-NEGATIVE BACTERIA; HUMANS; SENSITIVITY AND SPECIFICITY;

EID: 84882775790     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.00965-13     Document Type: Article

References (27)

1. Patel G, Huprikar S, Factor SH, Jenkins SG, Calfee DP. 2008. Outcomes of carbapenem-resistant Klebsiella pneumoniae infection and the impact of antimicrobial and adjunctive therapies. Infect. Control Hosp. Epidemiol. 29:1099-1106.
2. Landman D, Babu E, Shah N, Kelly P, Olawole O, Bäcker M, Bratu S, Quale J. 2012. Transmission of carbapenem-resistant pathogens in New York City hospitals: progress and frustration. J. Antimicrob. Chemother. 67:1427-1431.
3. Won SY, Munoz-Price LS, Lolans K, Hota B, Weinstein RA, Hayden MK, Centers for Disease Control and Prevention Epicenter Program. 2011. Emergence and rapid regional spread of Klebsiella pneumoniae carbapenemase-producing Enterobacteriaceae. Clin. Infect. Dis. 53:532-540.
4. Centers for Disease Control and Prevention. 2013. Healthcareassociated infections: tracking CRE. Centers for Disease Control and Prevention, Atlanta, GA. http://www.cdc.gov/hai/organisms/cre/Tracking CRE.html. Accessed 19 February 2013.
5. Kitchel B, Rasheed JK, Endimiani A, Hujer AM, Anderson KF, Bonomo RA, Patel JB. 2010. Genetic factors associated with elevated carbapenem resistance in KPC-producing Klebsiella pneumoniae. Antimicrob. Agents Chemother. 54:4201-4207.
6. Carvalhaes CG, Picao RC, Nicoletti AG, Xavier DE, Gales AC. 2010. Cloverleaf test (modified Hodge test) for detecting carbapenemase production in Klebsiella pneumoniae: be aware of false positive results. J. Antimicrob. Chemother. 65:249-251.
7. Girlich D, Poirel L, Nordmann P. 2012. Value of the modified Hodge test for detection of emerging carbapenemases in Enterobacteriaceae. J. Clin. Microbiol. 50:477-479.
8. Nordmann P, Poirel L, Dortet L. 2012. Rapid detection of carbapenemase-producing Enterobacteriaceae. Emerg. Infect. Dis. 18:1503-1507.
9. Dortet L, Poirel L, Nordmann P. 2012. Rapid detection of carbapenemase-producing Pseudomonas spp. J. Clin. Microbiol. 50:3773-3776.
10. Dortet L, Poirel L, Nordmann P. 2012. Rapid identification of carbapenemase types in Enterobacteriaceae and Pseudomonas spp. by using a biochemical test. Antimicrob. Agents Chemother. 56:6437-6440.
11. Centers for Disease Control and Prevention. 2008. Laboratory protocol for detection of carbapenem-resistant or carbapenemase-producing, Klebsiella spp. and E. coli from rectal swabs. Centers for Disease Control and Prevention, Atlanta, GA. http://www.cdc.gov/HAI/pdfs/labSettings /Klebsiella-or-Ecoli.pdf. Accessed 6 March 2013.
12. Thurlow CJ, Prabaker K, Lin MY, Lolans K, Weinstein RA, Hayden MK, Centers for Disease Control and Prevention Epicenters Program. 2013. Anatomic sites of patient colonization and environmental contamination with Klebsiella pneumoniae carbapenemase-producing Enterobacteriaceae at long-term acute care hospitals. Infect. Control Hosp. Epidemiol. 34:56-61.
13. Cunningham SA, Noorie T, Meunier D, Woodford N, Patel R. 23 January 2013. Rapid and simultaneous detection of genes encoding Klebsiella pneumoniae carbapenemase (blaKPC) and New Delhi metallo-betalactamase (blaNDM) in Gram-negative bacilli. J. Clin. Microbiol. doi:10 .1128/JCM.03062-12.
14. Hong SS, Kim K, Huh JY, Jung B, Kang MS, Hong SG. 2012. Multiplex PCR for rapid detection of genes encoding class A carbapenemases. Ann. Lab. Med. 32:359-361.
15. Poirel L, Naas T, Nicolas D, Collet L, Bellais S, Cavallo JD, Nordmann P. 2000. Characterization of VIM-2, a carbapenem-hydrolyzing metallobeta-lactamase and its plasmid-and integron-borne gene from a Pseudomonas aeruginosa clinical isolate in France. Antimicrob. Agents Chemother. 44:891-897.
16. Senda K, Arakawa Y, Ichiyama S, Nakashima K, Ito H, Ohsuka S, Shimokata K, Kato N, Ohta M. 1996. PCR detection of metallo-lactamase gene (blaIMP) in Gram-negative rods resistant to broadspectrum -lactams. J. Clin. Microbiol. 34:2909-2913.
17. Poirel L, Le Thomas I, Naas T, Karim A, Nordmann P. 2000. Biochemical sequence analyses of GES-1, a novel class A extended-spectrum betalactamase, and the class 1 integron In52 from Klebsiella pneumoniae. Antimicrob. Agents Chemother. 44:622-632.
18. Poirel L, Heritier C, Tolun V, Nordmann P. 2004. Emergence of oxacillinase-mediated resistance to imipenem in Klebsiella pneumoniae. Antimicrob. Agents Chemother. 48:15-22.
19. Perez-Perez FJ, Hanson ND. 2002. Detection of plasmid-mediated AmpC beta-lactamase genes in clinical isolates by using multiplex PCR. J. Clin. Microbiol. 40:2153-2162.
20. Kaczmarek FM, Dib-Hajj F, Shang W, Gootz TD. 2006. High-level carbapenem resistance in a Klebsiella pneumoniae clinical isolate is due to the combination of blaACT-1 beta-lactamase production, porin OmpK35/36 insertional inactivation, and down-regulation of the phosphate transport porin phoe. Antimicrob. Agents Chemother. 50:3396-3406.
21. Centers for Disease Control and Prevention. 2012. 2012 CRE toolkit-guidance for control of carbapenem-resistant Enterobacteriaceae (CRE). Centers for Disease Control and Prevention, Atlanta, GA. http://www.cdc .gov/hai/organisms/cre/cre-toolkit/index.html. Accessed 6 March 2013.
22. Health Protection Agency (UK)/Advisory Committee on Antimicrobial Resistance and Healthcare Associated Infections (ARHAI). 2011. Advice on carbapenemase producers: recognition, infection control and treatment. Health Protection Agency, London, United Kingdom. http://www .hpa.org.uk/webc/ HPAwebFile/HPAweb-c/1294740725984. Accessed 6 March 2013.
23. Centers for Disease Control and Prevention HAN. 2013. CDC Health Advisory: new carbapenem-resistant Enterobacteriaceae warrant additional action by healthcare providers. http://www.bt.cdc.gov/HAN/han0 0341.asp. Accessed 6 March 2013.
24. Walther-Rasmussen J, Hoiby N. 2006. OXA-type carbapenemases. J. Antimicrob. Chemother. 57:373-383.
25. Walther-Rasmussen J, Hoiby N. 2007. Class A carbapenemases. J. Antimicrob. Chemother. 60:470-482.
26. Yong D, Toleman MA, Giske CG, Cho HS, Sundman K, Lee K, Walsh TR. 2009. Characterization of a new metallo-beta-lactamase gene, blaNDM-1, and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India. Antimicrob. Agents Chemother. 53:5046-5054.
27. Naas T, Cuzon G, Truong HV, Nordmann P. 2012. Role of ISKpn7 and deletions in blaKPC gene expression. Antimicrob. Agents Chemother. 56: 4753-4759.